182 related articles for article (PubMed ID: 16424235)
1. Chronic pancreatitis: MRCP versus ERCP for quantitative caliber measurement and qualitative evaluation.
Tamura R; Ishibashi T; Takahashi S
Radiology; 2006 Mar; 238(3):920-8. PubMed ID: 16424235
[TBL] [Abstract][Full Text] [Related]
2. Administration of secretin (RG1068) increases the sensitivity of detection of duct abnormalities by magnetic resonance cholangiopancreatography in patients with pancreatitis.
Sherman S; Freeman ML; Tarnasky PR; Wilcox CM; Kulkarni A; Aisen AM; Jacoby D; Kozarek RA
Gastroenterology; 2014 Sep; 147(3):646-654.e2. PubMed ID: 24906040
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance cholangiopancreatography reports in the evaluation of chronic pancreatitis: a need for quality improvement.
Zuccaro P; Stevens T; Repas K; Diamond R; Lopez R; Wu B; Conwell DL
Pancreatology; 2009; 9(6):764-9. PubMed ID: 20110743
[TBL] [Abstract][Full Text] [Related]
4. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
Sahani DV; Kadavigere R; Blake M; Fernandez-Del Castillo C; Lauwers GY; Hahn PF
Radiology; 2006 Feb; 238(2):560-9. PubMed ID: 16436817
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic yield of ERCP and secretin-enhanced MRCP and EUS in patients with acute recurrent pancreatitis of unknown aetiology.
Mariani A; Arcidiacono PG; Curioni S; Giussani A; Testoni PA
Dig Liver Dis; 2009 Oct; 41(10):753-8. PubMed ID: 19278909
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of magnetic resonance cholangiopancreatography in identifying pancreatic duct disruption.
Drake LM; Anis M; Lawrence C
J Clin Gastroenterol; 2012 Sep; 46(8):696-9. PubMed ID: 22565603
[TBL] [Abstract][Full Text] [Related]
7. MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes.
Testoni PA; Mariani A; Curioni S; Zanello A; Masci E
Gastrointest Endosc; 2008 Jun; 67(7):1028-34. PubMed ID: 18179795
[TBL] [Abstract][Full Text] [Related]
8. Comparison of endoscopic retrograde cholangiopancreatography with MR cholangiopancreatography in patients with pancreatitis.
Sica GT; Braver J; Cooney MJ; Miller FH; Chai JL; Adams DF
Radiology; 1999 Mar; 210(3):605-10. PubMed ID: 10207456
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance cholangiopancreatography for the diagnostic evaluation of autoimmune pancreatitis.
Park SH; Kim MH; Kim SY; Kim HJ; Moon SH; Lee SS; Byun JH; Lee SK; Seo DW; Lee MG
Pancreas; 2010 Nov; 39(8):1191-8. PubMed ID: 20467343
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic diseases: evaluation with MR cholangiopancreatography.
Ueno E; Takada Y; Yoshida I; Toda J; Sugiura T; Toki F
Pancreas; 1998 Apr; 16(3):418-26. PubMed ID: 9548689
[TBL] [Abstract][Full Text] [Related]
11. Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis?
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Kodama M; Kamata N
Abdom Imaging; 2009; 34(3):381-4. PubMed ID: 18437450
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
[TBL] [Abstract][Full Text] [Related]
13. The detection of bile duct stones in suspected biliary pancreatitis: comparison of MRCP, ERCP, and intraductal US.
Moon JH; Cho YD; Cha SW; Cheon YK; Ahn HC; Kim YS; Kim YS; Lee JS; Lee MS; Lee HK; Shim CS; Kim BS
Am J Gastroenterol; 2005 May; 100(5):1051-7. PubMed ID: 15842578
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of three-dimensional magnetic resonance cholangiopancreatography with partial maximum intensity projection for diagnosing autoimmune pancreatitis.
Yanagisawa S; Fujinaga Y; Watanabe T; Maruyama M; Muraki T; Takahashi M; Fujita A; Fujita S; Kurozumi M; Ueda K; Hamano H; Kawa S; Kadoya M
Pancreatology; 2017; 17(4):567-571. PubMed ID: 28506431
[TBL] [Abstract][Full Text] [Related]
15. Utility of pancreatography for diagnosing autoimmune pancreatitis.
Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
World J Gastroenterol; 2011 May; 17(18):2332-7. PubMed ID: 21633599
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance study of the pancreatic duct.
Calvo MM; Calderón A; Heras I; Durán M; Orive V; Cabriada J; Astigarraga E
Rev Esp Enferm Dig; 1999 Apr; 91(4):287-96. PubMed ID: 10348928
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance-cholangiopancreatography in the diagnosis of biliopancreatic diseases.
Lomanto D; Pavone P; Laghi A; Panebianco V; Mazzocchi P; Fiocca F; Lezoche E; Passariello R; Speranza V
Am J Surg; 1997 Jul; 174(1):33-8. PubMed ID: 9240949
[TBL] [Abstract][Full Text] [Related]
18. Use of Magnetic Resonance Cholangiopancreatography in Clinical Practice: Not as Good as We Once Thought.
Aydelotte JD; Ali J; Huynh PT; Coopwood TB; Uecker JM; Brown CV
J Am Coll Surg; 2015 Jul; 221(1):215-9. PubMed ID: 26047762
[TBL] [Abstract][Full Text] [Related]
19. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
[TBL] [Abstract][Full Text] [Related]
20. MR cholangiopancreatography at 3.0 T: intraindividual comparative study with MR cholangiopancreatography at 1.5 T for clinical patients.
Onishi H; Kim T; Hori M; Murakami T; Tatsumi M; Nakaya Y; Nakamoto A; Osuga K; Tomoda K; Nakamura H
Invest Radiol; 2009 Sep; 44(9):559-65. PubMed ID: 19692840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
